SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (98)4/12/1998 11:51:00 AM
From: scaram(o)ucheRead Replies (1) of 4974
 
From the GNE 10-K, 3/4/98...... ever wondered who these guys are? I have. Let's keep an eye on them.

The Company is a limited partner in the Vector Later-Stage Equity Fund II,
L.P. (Vector Fund). The General Partner is Vector Fund Management II, L.L.C.,
a Delaware limited liability company. The purpose of the Vector Fund is to
invest in biotech equity and equity-related securities. Under the terms of
the Vector Fund agreement, the Company makes contributions to the capital of
the Vector Fund through installments in cash as called by the General Partner.
The Company's total commitment to the Vector Fund through September 2003 is
$25.0 million, of which $1.0 million was contributed as of December 31, 1997
and another $1.8 million was contributed in January 1998. The Vector Fund
will terminate and be dissolved in September 2007.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News